+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

North America Meningitis Imaging Market By Product Type, By Disease Type, By End User, By Country, Opportunity Analysis and Industry Forecast, 2021-2027

  • PDF Icon

    Report

  • 82 Pages
  • January 2022
  • Region: North America
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5552884
The North America Meningitis Imaging Market is expected to witness market growth of 4.2% CAGR during the forecast period (2021-2027).

The doctor must diagnose the chances of aetiology and rationally select some additional diagnostic tests based on a variety of factors such as patient history and symptomatology, regional epidemiology, and basic cerebrospinal fluid testing (protein, etc.) at the time of diagnosing meningitis.

Various developments in technology are improving the delivery of more speedy and accurate results. The Immuno-Mycologics cryptococcal antigen lateral flow assay has revolutionized cryptococcal diagnosis, and automated nucleic acid amplification techniques, which improved the bacterial and mycobacterial meningitis diagnosis. 

According to the United Nations Programme on HIV/AIDS (UNAIDS), 24.5 million HIV-positive persons worldwide received antiretroviral medication in 2019. Additionally, greater government intervention in controlling meningitis outbreaks and an increase in demand for immediate diagnosis systems is expected to create more demand for meningitis imaging. Between 2015 and 2019, there was an almost 30% increase in these reportable STDs.

The US market dominated the North America Meningitis Imaging Market by Country 2020, and is expected to continue to be a dominant market till 2027; thereby, achieving a market value of $70.7 Thousands by 2027. The Canada market is experiencing a CAGR of 6.6% during (2021 - 2027). Additionally, The Mexico market is expected to witness a CAGR of 5.6% during (2021 - 2027).

Based on Product Type, the market is segmented into Computer Tomography (CT), Magnetic Resonance Imaging (MRI) and Positron Emission Tomography. Based on Disease Type, the market is segmented into Viral Meningitis, Fungal Meningitis, Bacterial Meningitis and Others. Based on End User, the market is segmented into Hospitals & Clinics and Diagnostic Centers. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Shimadzu Corporation, Accuray, Incorporated, United Imaging Healthcare Co., Ltd., Positron Corporation, Neusoft Medical Systems Co., Ltd. (Neusoft Corporation), Siemens AG (Siemens Healthineers), Fujifilm Holdings Corporation, General Electric (GE) Co. (GE Healthcare), Koninklijke Philips N.V., and Canon, Inc. (Canon Medical Systems Corporation).

Scope of the Study


Market Segments Covered in the Report:


By Product Type

  • Computer Tomography (CT)
  • Magnetic Resonance Imaging (MRI) and
  • Positron Emission Tomography

By Disease Type

  • Viral Meningitis
  • Fungal Meningitis
  • Bacterial Meningitis and
  • Others

By End User

  • Hospitals & Clinics and
  • Diagnostic Centers

By Country

  • US
  • Canada
  • Mexico
  • Rest of North America

Key Market Players


List of Companies Profiled in the Report:

  • Shimadzu Corporation
  • Accuray, Incorporated
  • United Imaging Healthcare Co., Ltd.
  • Positron Corporation
  • Neusoft Medical Systems Co., Ltd. (Neusoft Corporation)
  • Siemens AG (Siemens Healthineers)
  • Fujifilm Holdings Corporation
  • General Electric (GE) Co. (GE Healthcare)
  • Koninklijke Philips N.V.
  • Canon, Inc. (Canon Medical Systems Corporation)

Unique Offerings from the Publisher

  • Exhaustive coverage
  • The highest number of market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Meningitis Imaging Market, by Product Type
1.4.2 North America Meningitis Imaging Market, by Disease Type
1.4.3 North America Meningitis Imaging Market, by End User
1.4.4 North America Meningitis Imaging Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2017-2021)
3.3.2 Key Strategic Move: (Product Launches and Product Expansions 2021, Aug - 2021, Dec) Leading Players
Chapter 4. North America Meningitis Imaging Market by Product Type
4.1 North America Computer Tomography (CT) Market by Country
4.2 North America Magnetic Resonance Imaging (MRI) Market by Country
4.3 North America Positron Emission Tomography Market by Country
Chapter 5. North America Meningitis Imaging Market by Disease Type
5.1 North America Viral Meningitis Market by Country
5.2 North America Fungal Meningitis Market by Country
5.3 North America Bacterial Meningitis Market by Country
5.4 North America Others Market by Country
Chapter 6. North America Meningitis Imaging Market by End User
6.1 North America Hospitals & Clinics Market by Country
6.2 North America Diagnostic Centers Market by Country
Chapter 7. North America Meningitis Imaging Market by Country
7.1 US Meningitis Imaging Market
7.1.1 US Meningitis Imaging Market by Product Type
7.1.2 US Meningitis Imaging Market by Disease Type
7.1.3 US Meningitis Imaging Market by End User
7.2 Canada Meningitis Imaging Market
7.2.1 Canada Meningitis Imaging Market by Product Type
7.2.2 Canada Meningitis Imaging Market by Disease Type
7.2.3 Canada Meningitis Imaging Market by End User
7.3 Mexico Meningitis Imaging Market
7.3.1 Mexico Meningitis Imaging Market by Product Type
7.3.2 Mexico Meningitis Imaging Market by Disease Type
7.3.3 Mexico Meningitis Imaging Market by End User
7.4 Rest of North America Meningitis Imaging Market
7.4.1 Rest of North America Meningitis Imaging Market by Product Type
7.4.2 Rest of North America Meningitis Imaging Market by Disease Type
7.4.3 Rest of North America Meningitis Imaging Market by End User
Chapter 8. Company Profiles
8.1 Shimadzu Corporation
8.1.1 Company Overview
8.1.1 Financial Analysis
8.1.2 Segmental and Regional Analysis
8.1.3 Research & Development Expense
8.1.4 Recent strategies and developments
8.1.4.1 Acquisition and Mergers:
8.2 Accuray Incorporated
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Regional Analysis
8.2.4 Research & Development Expenses
8.2.5 Recent strategies and developments
8.2.5.1 Product Launches and Product Expansions
8.3 United Imaging Healthcare Co., Ltd.
8.3.1 Company Overview
8.4 Positron Corporation
8.4.1 Company Overview
8.5 Neusoft Medical Systems Co., Ltd. (Neusoft Corporation)
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Research & Development Expenses
8.6 Siemens Healthineers AG (Siemens AG)
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expenses
8.6.5 Recent strategies and developments
8.6.5.1 Product Launches and Product Expansions
8.6.5.2 Acquisition and Mergers:
8.7 Fujifilm Holdings Corporation
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expenses
8.7.5 Recent strategies and developments
8.7.5.1 Acquisitions and Mergers:
8.7.5.2 Product Launches and Product Expansions
8.8 General Electric (GE) Co. (GE Healthcare)
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expense
8.8.5 Recent strategies and developments
8.8.5.1 Partnerships, Collaborations, and Agreements
8.8.6 SWOT Analysis
8.9 Koninklijke Philips N.V.
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expense
8.9.5 Recent strategies and developments
8.9.5.1 Partnerships, Collaborations, and Agreements
8.10. Canon, Inc. (Canon Medical Systems Corporation)
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Segmental and Regional Analysis
8.10.4 Research & Development Expenses
8.10.5 Recent strategies and developments
8.10.5.1 Partnerships, Collaborations, and Agreements
8.10.5.2 Product Launches and Product Expansions
8.10.5.3 Acquisition and Mergers:

Companies Mentioned

  • Shimadzu Corporation
  • Accuray, Incorporated
  • United Imaging Healthcare Co., Ltd.
  • Positron Corporation
  • Neusoft Medical Systems Co., Ltd. (Neusoft Corporation)
  • Siemens AG (Siemens Healthineers)
  • Fujifilm Holdings Corporation
  • General Electric (GE) Co. (GE Healthcare)
  • Koninklijke Philips N.V.
  • Canon, Inc. (Canon Medical Systems Corporation)

Methodology

Loading
LOADING...